rs145216283

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004204.5(PIGQ):​c.925C>G​(p.Leu309Val) variant causes a missense change. The variant allele was found at a frequency of 0.00183 in 1,554,050 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L309L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00099 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0019 ( 3 hom. )

Consequence

PIGQ
NM_004204.5 missense

Scores

1
3
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.79

Publications

4 publications found
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
PIGQ Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 77
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017574817).
BP6
Variant 16-576237-C-G is Benign according to our data. Variant chr16-576237-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 526287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000991 (151/152366) while in subpopulation NFE AF = 0.00179 (122/68028). AF 95% confidence interval is 0.00153. There are 0 homozygotes in GnomAd4. There are 71 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.925C>G p.Leu309Val missense_variant Exon 4 of 11 ENST00000321878.10 NP_004195.2 Q9BRB3-2B2RAU6
PIGQNM_148920.4 linkc.925C>G p.Leu309Val missense_variant Exon 4 of 10 NP_683721.1 Q9BRB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.925C>G p.Leu309Val missense_variant Exon 4 of 11 1 NM_004204.5 ENSP00000326674.6 Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.000992
AC:
151
AN:
152248
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00109
AC:
172
AN:
157760
AF XY:
0.00111
show subpopulations
Gnomad AFR exome
AF:
0.000654
Gnomad AMR exome
AF:
0.000435
Gnomad ASJ exome
AF:
0.00201
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000726
Gnomad NFE exome
AF:
0.00180
Gnomad OTH exome
AF:
0.000678
GnomAD4 exome
AF:
0.00192
AC:
2686
AN:
1401684
Hom.:
3
Cov.:
34
AF XY:
0.00183
AC XY:
1268
AN XY:
691786
show subpopulations
African (AFR)
AF:
0.000282
AC:
9
AN:
31938
American (AMR)
AF:
0.000386
AC:
14
AN:
36260
Ashkenazi Jewish (ASJ)
AF:
0.00147
AC:
37
AN:
25192
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36304
South Asian (SAS)
AF:
0.000679
AC:
54
AN:
79556
European-Finnish (FIN)
AF:
0.000440
AC:
21
AN:
47774
Middle Eastern (MID)
AF:
0.000361
AC:
2
AN:
5542
European-Non Finnish (NFE)
AF:
0.00230
AC:
2484
AN:
1081000
Other (OTH)
AF:
0.00112
AC:
65
AN:
58118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
150
300
450
600
750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000991
AC:
151
AN:
152366
Hom.:
0
Cov.:
34
AF XY:
0.000953
AC XY:
71
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41592
American (AMR)
AF:
0.000131
AC:
2
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4834
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00179
AC:
122
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00148
Hom.:
0
Bravo
AF:
0.00114
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000700
AC:
3
ESP6500EA
AF:
0.00142
AC:
12
ExAC
AF:
0.000697
AC:
77
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGQ: BP4 -

PIGQ-related disorder Benign:1
Oct 18, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.048
.;.;.;T
Eigen
Benign
0.072
Eigen_PC
Benign
0.072
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
.;D;D;D
M_CAP
Benign
0.074
D
MetaRNN
Benign
0.018
T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.4
L;L;.;L
PhyloP100
3.8
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.82
N;N;N;N
REVEL
Benign
0.28
Sift
Benign
0.17
T;T;D;T
Sift4G
Benign
0.20
T;T;D;T
Polyphen
0.75
P;P;.;P
Vest4
0.61
MVP
0.63
MPC
0.41
ClinPred
0.024
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.59
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145216283; hg19: chr16-626237; API